Intravenous Ketamine for Adolescents with Treatment-Resistant Depression: An Open-Label Study.
Journal of Child and Adolescent Psychopharmacology September 2018 Kathryn R. Cullen, Palistha Amatya, Mark G Roback et al.
Novel interventions for treatment-resistant depression (TRD) in adolescents are urgently needed. Ketamine has been studied in adults with TRD, but little information is available for adolescents. This study investigated efficacy and tolerability of intravenous ketamine in adolescents with TRD, and explored clinical response predictors. Adolescents, 12-18 years of age, with TRD (failure to...
DOI: 10.1089/cap.2018.0030 (opens in new tab)
Full text (opens in new tab)
Depression
Ketamine
Adolescent
Treatment-resistant